跳至主要内容
临床试验/NCT04755972
NCT04755972已完成不适用

Mucolytic Agents and Ventilator-associated Pneumonia in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2

Clinical Hospital Center, Split2 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2020年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
175
试验地点
2
主要终点
Difference between 4 arms regarding ventilator-associated pneumonia rate

研究概览

简要总结

It is planned to include patients over 18 years of age of both sexes, admitted to the Intensive Care Unit of Clinical Hospital Centre Split for respiratory insufficiency caused by severe acute respiratory syndrome coronavirus 2 in need of invasive mechanical ventilation.

The patients will be divided into four groups. Group 1 will receive N-acetylcysteine inhalation, Group 2 will receive inhalation with a 5% sodium chloride solution, and Group 3 will receive inhalation of 8.4% sodium bicarbonate, group 4 is a control group and will not routinely receive inhaled mucolytics preventively.

All inhalations will be given twice a day 12 hours apart. The first inhalation will be included within 12 hours of the patient being enrolled in the Intensive Care Unit. Patients will be randomized according to the type of inhalation they will receive, randomization will be done by all researchers through the random.org website, and the inhalation will be given by a nurse according to the agreed protocol.

RESEARCH GOALS

The aim of this study is to determine whether there is a difference in the frequency and duration of ventilator-associated pneumonia (VAP) and whether there is a difference in the number of days spent on mechanical ventilation and in mortality in these four groups of patients.

Hypothesis

Coronavirus disease 2019 patients on invasive mechanical ventilation and preventive sodium bicarbonate inhalation will have a lower incidence of ventilator-associated pneumonia and fewer days spent on invasive mechanical ventilation than patients inhaled with N-acetylcysteine, 5% saline, or patients without preventive inhalation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years of age with coronavirus pneumonia who need invasive mechanical ventilation.

排除标准

  • Patients with polytrauma,
  • pregnant women,
  • severe hemodynamic instability,
  • patients with pulmonary edema,
  • less than 3 days spent in the ICU,
  • patients who have microbiologically proven bacterial infection on arrival.

结局指标

主要结局

Difference between 4 arms regarding ventilator-associated pneumonia rate

时间窗: Through study completion, an average of 6 months.

Patients will be monitored for ventilator-associated pneumonia according to clinical criteria with a new or progressive pulmonary infiltrate on imaging plus supportive clinical findings of infection (eg, fever, secretions, leukocytosis). The diagnosis is confirmed when lower respiratory tract sampling identifies a pathogen.

次要结局

  • Number of ventilator-free days(Day 28 after ICU admission.)
  • Mortality(Day 28 after ICU admission.)

研究者

发起方
Clinical Hospital Center, Split
申办方类型
Other
责任方
Principal Investigator
主要研究者

Nikola Delić

MD, intensive care specialist

Clinical Hospital Center, Split

研究点 (2)

Loading locations...

相似试验